lymphoid leukemia
Showing 1 - 16 of 16
Breast Cancer, Hodgkin Lymphoma, Kidney Cancer Trial (Assessment tool IA3-CP with SDoH, Assessment tool IA3-CP without SDoH)
Not yet recruiting
- Breast Cancer
- +9 more
- Assessment tool IA3-CP with SDoH
- Assessment tool IA3-CP without SDoH
- (no location specified)
May 22, 2023
Pediatric and Young Adult B-Cell Malignancies After Commercially
Not yet recruiting
- Lymphoid Leukemia
- Questionnaire for patients receiving therapy
-
Palo Alto, CaliforniaStanford University
May 9, 2023
Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)
Completed
- Lymphoid Leukemia
- +2 more
- Bendamustine
- +2 more
-
Madison, WisconsinUniversity of Wisconsin
Jan 30, 2023
Lymphoid Leukemia, Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Tampa (CPX-351)
Active, not recruiting
- Lymphoid Leukemia
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022
Lymphoid Leukemia Trial in Palo Alto (Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector
Not yet recruiting
- Lymphoid Leukemia
- Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)
- Treg CD34+ HSPC (Orca-T)
-
Palo Alto, CaliforniaStanford Cancer Center
Aug 17, 2022
Bone and Joints, Brain and Nervous System, Leukemia, NOS Trial in San Francisco (GOLD Program, Treatment as usual (TAU))
Recruiting
- Bone and Joints
- +4 more
- GOLD Program
- Treatment as usual (TAU)
-
San Francisco, CaliforniaStanford Cancer Institute
Jun 8, 2022
Hodgkin Lymphoma, Lymphoid Leukemia, Multiple Myeloma Trial in Richmond (Intravenous (IV) and oral Vitamin C)
Active, not recruiting
- Hodgkin Lymphoma
- +6 more
- Intravenous (IV) and oral Vitamin C
-
Richmond, VirginiaVirginia Commonwealth University/ Massey Cancer Center
Mar 2, 2022
Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)
Active, not recruiting
- Hodgkin's Lymphoma
- +17 more
- mycophenolate mofetil
- +2 more
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Dec 21, 2021
Healthy Bones, Healthy Life
Recruiting
- Acute Lymphoblastic Leukemia, Pediatric
- +12 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Dec 10, 2021
Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Myeloid Leukemia Trial in Detroit (Dasatinib, laboratory biomarker analysis)
Terminated
- Non-Hodgkin's Lymphoma
- +5 more
- Dasatinib
- laboratory biomarker analysis
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Dec 14, 2020
Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Plasma Cell Myeloma Trial in Madison (Behavioral techniques)
Completed
- Hodgkin Lymphoma
- +6 more
- Behavioral techniques
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Nov 13, 2019
Hodgkin's Lymphoma, Leukemia, Lymphoid Leukemia Trial in Madison (Behavioral techniques)
Completed
- Hodgkin's Lymphoma
- +6 more
- Behavioral techniques
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Nov 14, 2019
Acute Myeloid Leukemia, Lymphoid Leukemia Trial (Oshadi D & Oshadi R;, salvage therapy cytosar and mitoxantrone)
Suspended
- Acute Myeloid Leukemia
- Lymphoid Leukemia
- Oshadi D & Oshadi R;
- salvage therapy cytosar and mitoxantrone
- (no location specified)
Apr 16, 2018
Acute Myelogenous Leukemia, Lymphoid Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (Fludarabine, Melphalan, Stem
Completed
- Acute Myelogenous Leukemia
- +8 more
- Fludarabine
- +3 more
-
Chicago, IllinoisThe University of Chicago
Oct 7, 2016
Lymphoid Leukemia Trial in Bologna (doxorubicin liposomal)
Unknown status
- Lymphoid Leukemia
- doxorubicin liposomal
-
Bologna, ItalyInstitute of Hematology "L. & A. Seragnoli"
Sep 14, 2009